July 8th 2024
When used together, sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) were able to lower the risk of major adverse cardiovascular events and kidney disease by 11% and 33%, respectively.
Maximizing Patient Outcomes Through Pharmacist-Led Homozygous Familial Hypercholesterolemia Management
1.0 Credit / Cardiology
View More
Setting the Stage: An Introduction to Worsening Heart Failure Events in Patients With Heart Failure With Reduc...
1.0 Credit / Cardiology
View More
Understanding the Challenges of Homozygous Familial Hypercholesterolemia
1.0 Credit / Cardiology
View More
The Role of the Pharmacist in Optimizing DOAC Utilization Across Practice Settings
1.0 Credit / Cardiology
View More
Navigating the Therapeutic Landscape of Homozygous Familial Hypercholesterolemia
1.0 Credit / Cardiology
View More
Soluble Guanylate Cyclase Stimulators in the Management of Worsening Heart Failure With Reduced Ejection Fract...
1.0 Credit / Cardiology
View More
Individualizing Care for Patients With Heart Failure: The Role of the Pharmacist in Optimizing Education and I...
1.0 Credit / Cardiology
View More
Advancing Chronic Worsening Heart Failure Treatment: The Critical Role of Pharmacists in Therapy Integration
1.0 Credit / Cardiology
View More
Iron Deficiency and Anemia in Heart Failure: Clinical Applications for the Use of Intravenous Iron
1.5 Credits / Cardiology
View More
Advances and Best Practices for Managed Care Pharmacists in the Treatment of Heart Failure with Preserved Ejec...
1.0 Credits / Cardiology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Lipoprotein(a) and Beyond: Emerging Paradigms in Atherosclerotic Cardiovascular Disease Prevention
1.5 Credits / Cardiology
View More
The Utilization of SGLT2 Inhibitors in the Treatment of Cardiovascular Disease, Diabetes, and Chronic Kidney D...
1.5 Credits / Cardiology; Endocrinology, Diabetes & Metabolism; Nephrology
View More
Optimizing Care for Chronic Worsening Heart Failure: The Key Role of Pharmacists in Integrating Therapies
1.5 Credits / Cardiology
View More
The Evolving Treatment Paradigm for the Management of Pulmonary Arterial Hypertension: Strategies to Optimize ...
1.5 Credits / Cardiology
View More
Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment
1.5 Credits / Cardiology, Neurology, Rare Diseases
View More
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
Elevating Cardiac Care: Insights From Pharmacists Across Practice Settings
1.0 Credit / Cardiology
View More
Updated Guidelines in the Management of Atrial Fibrillation and Application for Pharmacists
1.5 Credits / Cardiology
View More
The Expanding Role of Nonstatin Therapies in Reducing LDL-Cholesterol Levels to Prevent and Manage ASCVD: A Re...
1.5 Credits / Cardiology
View More
Recent Developments in the Management of Heart Failure With Preserved Ejection Fraction
1.0 Credit / Cardiology
View More
Therapies in Lowering LDL-Cholesterol Levels for the Primary and Secondary Prevention of Atherosclerotic Cardi...
0.75 Credit / Cardiology
View More
Pharmacist-Led Intervention Could Help Lower Rates of Inappropriate Aspirin Use
December 5th 2023Updated guidance from the United States Preventive Services Task Force advises against low-dose aspirin use as a primary prevention of atherosclerotic cardiovascular disease in certain populations who have bleeding risks.